title: Sequential clinical and immunological follow-up shows similar evolution during the first trimester after renal transplantation in patients receiving azathioprine or not.
authors.forename: E
authors.initials: E
authors.lastname: Renowt
authors.forename: C
authors.initials: C
authors.lastname: Béne
authors.forename: D
authors.initials: D
authors.lastname: Hestin
authors.forename: I
authors.initials: I
authors.lastname: Karleskind
authors.forename: G
authors.initials: G
authors.lastname: Faure
authors.forename: M
authors.initials: M
authors.lastname: Kessler
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D015166:Monitoring, Immunologic; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone